Patent details

EP2727918 Title: Compounds and Compositions as Protein Kinase Inhibitors

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2727918
WO Application Number:
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP14152945.3
WO Publication Number:
EPO Publication Language:
English
SPC Number:
300975
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
27/08/2010
Grant date:
12/10/2016
EP Publication Date:
07/05/2014
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
12/01/2017
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
12/10/2016
EP B1 Publication Date:
12/10/2016
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
26/08/2030
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
28/06/2019
 
 

 

Name:
Array BioPharma Inc.
Address:
3200 Walnut Street, 80301, Boulder, CO, United States of America (US)

Historical Applicant/holder

From:
12/10/2016
To:
28/06/2019

 

Name:
Array Biopharma Inc.
Address:
3200 Walnut Street, BOULDER, CO 80301, United States of America (US)

Domicile Holder

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
12/01/2017
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
Huang, Shenlin
Address:
San Diego, CA 92130, United States of America (US)

2

Name:
Jin, Xianming
Address:
San Ramon, CA 94582, United States of America (US)

3

Name:
Liu, Zuosheng
Address:
San Diego, CA 92130, United States of America (US)

4

Name:
Poon, Daniel
Address:
Piedmont, CA 94611, United States of America (US)

5

Name:
Tellew, John
Address:
La Jolla, CA 92037, United States of America (US)

6

Name:
Wan, Yongqin
Address:
San Diego, CA 92121, United States of America (US)

7

Name:
Wang, Xing
Address:
San Diego, CA 92127, United States of America (US)

8

Name:
Xie, Yongping
Address:
San Diego, CA 92129, United States of America (US)

Licensee

Name:
Pierre Fabre Medicament
From:
27/06/2018
Address:
45 Place Abel Gance, 92100, Boulogne-Billancourt, France (FR)
To:

Priority

1

Priority Patent Number:
313039 P
Priority Date:
11/03/2010
Priority Country:
United States of America (US)

2

Priority Patent Number:
238073 P
Priority Date:
28/08/2009
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 31/506; A61P 35/00; C07D 401/14; C07D 403/04;

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
28/19
Publication date:
10/07/2019
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
MED
Journal edition number:
28/18
Publication date:
04/07/2018
Description:
Other communications

3

Bulletin Heading:
EP3
Journal edition number:
04/17
Publication date:
25/01/2017
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

4

Bulletin Heading:
EP2
Journal edition number:
41/16
Publication date:
12/10/2016
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
201647
Publication date:
23/11/2016
Description:
Application number/publication number of the divisional application (Art. 76) changed

2

Issue number:
201646
Publication date:
16/11/2016
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
201641
Publication date:
12/10/2016
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name
Deed Number:
RC201901285A
Date Registered:
28/06/2019
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. H.A. Witmans c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Array BioPharma Inc.
Address:
3200 Walnut Street, 80301, Boulder, CO, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Licence

Change Kind/ Decision Type:
New licence registration
Deed Number:
RC201801156A
Date Registered:
27/06/2018
License Effective Date:
27/06/2018
License Expiration Date:
Scope of License:
Exclusive
Deed Filer:
ir. A.R. Aalbers
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Licensee(s)

Name:
Pierre Fabre Medicament
Address:
45 Place Abel Gance, 92100, Boulogne-Billancourt, France (FR)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
31/08/2025
Annual Fee Number:
16
Annual Fee Amount:
1000 Euro
Last Annual Payment Date:
11/07/2024
Last Annual Fee Paid Number:
15
Last Annual Fee Paid Amount:
900 Euro
Payer:
Master Data Center
Filing date Document type Document Description Number of pages File Type
28/06/2018 Outgoing Correspondence Letter registration deed 1 PDF /5/5/5/7/9/0800097555/docs/ep14152945.3_2_215094l119.pdf
19/01/2017 Outgoing Correspondence Letter no formal defects 1 PDF /5/5/5/7/9/0800097555/docs/ep14152945.3_0_111777l271.pdf
12/01/2017 Claims First filed claims 4 PDF /5/5/5/7/9/0800097555/docs/ep14152945.3_1_claims20170112123841298.pdf
12/01/2017 Incoming Correspondence Electronic Accompanying letter incoming document 2 PDF /5/5/5/7/9/0800097555/docs/ep14152945.3_3_incomingcorrespondenceelectronic20170112123842141.pdf